Sutro Biopharma (STRO) Interest & Investment Income (2017 - 2026)
Sutro Biopharma (STRO) posted Interest & Investment Income of -$782000.0 for Q4 2025, down 6.11% sequentially from -$737000.0 in Q3 2025, and up 90.27% YoY from -$410987.1 in Q4 2024.
Sutro Biopharma (STRO) Interest & Investment Income (2017 - 2026) Analysis & Trends
Sutro Biopharma has reported Interest & Investment Income for 9 years, with the latest figure at -$782000.0 in Q4 2025.
- Quarterly Interest & Investment Income rose 90.27% year-over-year to -$782000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (down 58.75% YoY) and the FY2025 annual result came in at -$3.9 million, down 120.68% from the prior year.
- Interest & Investment Income eased to -$782000.0 in Q4 2025 per STRO's latest filing, from -$737000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $22.2 million in Q3 2024 and troughed at -$8.0 million in Q4 2024.
- A 5-year average of $802500.0 and a median of $102500.0 in 2021 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income surged 7706.25% in 2022, then plunged 2674.14% in 2023.
- Over 5 years, Interest & Investment Income stood at $96000.0 in 2021, then soared by 7706.25% to $7.5 million in 2022, then sank by 133.89% to -$2.5 million in 2023, then slumped by 216.54% to -$8.0 million in 2024, then surged by 90.27% to -$782000.0 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$782000.0, -$737000.0, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Dec 31, 2025 | -782,000.00 |
| Sep 30, 2025 | -737,000.00 |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 3.19 Mn |
| Dec 31, 2024 | -8.04 Mn |
| Sep 30, 2024 | 22.17 Mn |
| Jun 30, 2024 | -1.76 Mn |
| Mar 31, 2024 | -2.21 Mn |
| Dec 31, 2023 | -2.54 Mn |
| Sep 30, 2023 | 4.55 Mn |
| Jun 30, 2023 | -2.92 Mn |
| Mar 31, 2023 | -2.99 Mn |
| Dec 31, 2022 | 7.49 Mn |
| Sep 30, 2022 | -2.79 Mn |
| Jun 30, 2022 | 197,000.00 |
| Mar 31, 2022 | 116,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 175,000.00 |